Reduced Frequency of Biological and Increased Frequency of Adopted Children in Males With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Context: Fertility in males with 21-hydroxylase deficiency (21OHD) is unclear. Objective: Study fertility outcome in males with congenital adrenal hyperplasia. Design, Setting, and Participants: Males ≥15 years old with 21OHD (n = 221) were compared with controls matched for sex and year and place of birth (n = 22,024). Data were derived by linking national population-based registers. Subgroup analyses were performed regarding phenotype [salt-wasting (SW), simple virilizing (SV), and nonclassic (NC)] and CYP21A2 genotype (null, I2 splice, I172N, and P30L) and stratified by the introduction of neonatal screening. Main Outcome Measures: Number of biological and adopted children. Results: Males with 21OHD were less likely to be fathers of biological children [odds ratio (OR), 0.5; 95% confidence interval (CI), 0.4 to 0.7; after adjusting for socioeconomic characteristics: OR, 0.4; 95% CI, 0.2 to 0.5]. This was true for SW, SV, I2 splice, and I172N, but not for NC, null, and P30L groups (all adjusted). Among patients born before the neonatal screening introduction, fewer were fathers (adjusted OR, 0.3; 95% CI, 0.2 to 0.5), but this normalized in those born afterward. Adoption was more common in the 21OHD males (OR, 2.9; 95% CI, 1.0 to 7.9) and the SV and I172N subgroups. Age at becoming a father, marriage, region of residence, and education were similar, but fewer patients had high incomes. NC and I172N groups had, however, higher academic degrees and NC patients were more often married, whereas SW and I2 splice patients were more often divorced. Conclusions: 21OHD was associated with a reduced frequency of biological children and an increased frequency of adopted children, suggesting impaired fertility, although some subgroups had normal fertility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although TART is thought to be the main cause of male infertility in CAH, improvements have been observed in male fertility in those born after the introduction of neonatal screening, which suggests that early diagnosis and treatment might benefit gonadal development and function103.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [103]
The cited source says what the claim attributes to it.
In the citing paper
“Similar risks were found in a mixed group of men with CAH and NCCAH (247).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [247]
In the citing paper
“In one study, males with CAH born after the introduction of neonatal screening had normal fertility (247).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [247]
In the citing paper
“One study reported that fewer men with CAH had stable heterosexual relationships than did age-matched controls (255), whereas more recent data showed no such differences in relationships but a reduction in sexual activity among men with CAH (247).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [247]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Hines, M., Brook, C., & Conway, G. S. (2004) · Journal of Sex Research · doi:10.1080/00224490409552215 · Cited by 439
Stikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305
Predictors of Outcome of Long-Term GnRH Therapy in Men with Idiopathic Hypogonadotropic Hypogonadism
Pitteloud, N., Hayes, F. J., Dwyer, A., Boepple, P. A., Lee, H., & Crowley, W. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020518 · Cited by 243
Hagenfeldt, K., Janson, P. O., Holmdahl, G., Falhammar, H., Filipsson, H., Frisen, L., Thoren, M., & Nordenskjold, A. (2008) · Human Reproduction · doi:10.1093/humrep/den118 · Cited by 205
Self-citationFalhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Self-citationLong Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204
Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196
Self-citationAdult Height and Fertility in Men with Congenital Virilizing Adrenal Hyperplasia
Urban, M. D., Lee, P. A., & Migeon, C. J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812212992505 · Cited by 196
Research works printed but not linked: 1
- Falhammar H, Filipsson Nystrom H, Wedell A, Thoren M. Car- diovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol. 2011;164(2):285-293.
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationEngels, M., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., & Claahsen-van der Grinten, H. L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00258 · Cited by 163
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Self-citationManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Al Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
Self-citationMANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Stikkelbroeck, N., Falhammar, H., & Reisch, N. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1093 · Cited by 72
Self-citationGonadal function in adult male patients with congenital adrenal hyperplasia
Engels, M., Gehrmann, K., Falhammar, H., Webb, E. A., Nordenström, A., Sweep, F. C., Span, P. N., van Herwaarden, A. E., Rohayem, J., Richter-Unruh, A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0862 · Cited by 69
Self-citationHirschberg, A. L., Gidlöf, S., Falhammar, H., Frisén, L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa801 · Cited by 65
Self-citationBilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
MacKay, D., Nordenström, A., & Falhammar, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00217 · Cited by 59
Self-citationFalhammar, H., Lindh, J. D., Calissendorff, J., Skov, J., Nathanson, D., & Mannheimer, B. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.08.012 · Cited by 61
Self-citationKocova, M., Janevska, V., & Anastasovska, V. (2018) · Endocrine Connections · doi:10.1530/ec-18-0097 · Cited by 51
Falhammar, H., Lindh, J. D., Calissendorff, J., Farmand, S., Skov, J., Nathanson, D., & Mannheimer, B. (2018) · Seizure · doi:10.1016/j.seizure.2018.04.025 · Cited by 55
Self-citationSexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review
Daae, E., Feragen, K. B., Waehre, A., Nermoen, I., & Falhammar, H. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00038 · Cited by 50
Self-citationDaae, E., Feragen, K. B., Nermoen, I., & Falhammar, H. (2018) · Endocrine · doi:10.1007/s12020-018-1723-0 · Cited by 45
Self-citationAntipsychotics and severe hyponatremia: A Swedish population–based case–control study
Falhammar, H., Lindh, J. D., Calissendorff, J., Skov, J., Nathanson, D., & Mannheimer, B. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.11.011 · Cited by 50
Self-citationFalhammar, H., Frisén, L., Hirschberg, A. L., Nordenskjöld, A., Almqvist, C., & Nordenström, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab712 · Cited by 42
Self-citationLong-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 49
“For patients born before the screening the likelihood to father a child was halved [98].”
Self-citationFalhammar, H., Skov, J., Calissendorff, J., Nathanson, D., Lindh, J. D., & Mannheimer, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa194 · Cited by 39
“The NPR, the Swedish Prescribed Drug Register and the LISA register were all linked (27,30,31).”
BackgroundSelf-citationTramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study
Falhammar, H., Calissendorff, J., Skov, J., Nathanson, D., Lindh, J. D., & Mannheimer, B. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.08.006 · Cited by 34
Self-citationKocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Self-citationLong‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
“TARTs are benign testicular lesions 19,22,25,27,35,36 histologically resembling adrenocortical cells with features of a steroid producing tissue.”
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 26
Self-citationFalhammar, H., Frisén, L., Hirschberg, A. L., Nordenskjöld, A., Almqvist, C., & Nordenström, A. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00122 · Cited by 23
“This cohort was updated through 2013 (previously 2009) [22], and hence more individuals have been included than in the cohort we reported in previous studies [5, 18–21].”
Self-citationEkbom, K., Strandqvist, A., Lajić, S., Hirschberg, A. L., Falhammar, H., & Nordenström, A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14676 · Cited by 23
“The introduction of the programme has resulted in improvements being seen in several health outcomes.(36,37)”
BackgroundSelf-citationLajić, S., Karlsson, L., Zetterström, R. H., Falhammar, H., & Nordenström, A. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030068 · Cited by 25
“In the Swedish epidemiological study including 221 males with CAH only those born before the neonatal screening had impaired fertility while those born after the introduction of screening had normalized fertility compared to same age controls [27].”
BackgroundSelf-citationRussian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Lolis, E., Juhlin, C. C., Nordenström, A., & Falhammar, H. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00082 · Cited by 20
“The balance between under- and overtreatment has always been a challenge in patients with CAH.”
BackgroundSelf-citationChallenges Waiting for an Adult with DSD
Nowotny, H. F., & Reisch, N. (2022) · Hormone Research in Paediatrics · doi:10.1159/000527433 · Cited by 25
Burman, P., Falhammar, H., Waldenström, E., Sundin, A., & Bitzèn, U. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa870 · Cited by 19
Self-citationder Grinten, H. L. C., Adriaansen, B. P. H., & Falhammar, H. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae718 · Cited by 19
Self-citationCharacteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Kocova, M., Concolino, P., & Falhammar, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.788812 · Cited by 15
Self-citationClinical outcomes in 21-hydroxylase deficiency
Nordenström, A., Lajić, S., & Falhammar, H. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000625 · Cited by 15
Self-citationNordenström, A., Svensson, J., Lajić, S., Frisén, L., Nordenskjöld, A., Norrby, C., Almqvist, C., & Falhammar, H. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01199 · Cited by 15
Self-citationQuality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Verhees, M. J. M., Engels, M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., Falhammar, H., Nordenström, A., Webb, E. A., Richter-Unruh, A., Bouvattier, C. M., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626646 · Cited by 19
Self-citationSchröder, M. A. M., Neacşu, M., Adriaansen, B. P. H., Sweep, F. C. G. J., Ahmed, S. F., Ali, S., Bachega, T. A. S. S., Baronio, F., Birkebæk, N., de Bruin, C., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad143 · Cited by 15
“Previously, a large epidemiological study by Falhammar et al. [35] reported that fertility outcomes (number of men that fathered a child) normalized for men with CAH after the introduction of neonatal screening.”
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
“Such a correlation between genotype severity and having biological children was not seen in males with CAH [91].”
Self-citationDörr, H. G., Heß, J., Penger, T., Marx, M., & Oppelt, P. G. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2091-8 · Cited by 13
“Recently, this finding was also reported in men with classic CAH [21].”
ResultSexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency
Gehrmann, K., Engels, M., Bennecke, E., Bouvattier, C. M., Falhammar, H., Kreukels, B. P. C., Nordenström, A., Reisch, N., Gehrmann, N., Stikkelbroeck, N. M. M. L., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00082 · Cited by 14
Self-citationFalhammar, H., Skov, J., Calissendorff, J., Lindh, J. D., & Mannheimer, B. (2019) · Endocrine · doi:10.1007/s12020-019-02160-z · Cited by 10
Self-citationFalhammar, H., Skov, J., Calissendorff, J., Lindh, J. D., & Mannheimer, B. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120937597 · Cited by 10
“The NPR, The Swedish Prescribed Drug Register (SPDR) and the LISA register were utilized (Falhammar et al., 2015, 2017; Wettermark et al., 2007).”
MethodSelf-citationLottspeich, C., Müller-Lisse, U., Seiler, L., Schmitt-Graeff, A. H., Reincke, M., & Reisch, N. (2019) · Urology · doi:10.1016/j.urology.2019.03.005 · Cited by 9
“Based on recent Swedish population-based data, fertility rates in male CAH are diverse with reduced number of biological children suggesting impaired fertility, but also normal fertility in some subgroups.(18) Impaired sperm production in patients with CAH is not only caused by TARTs but also hypogonadotropic hypogona…”
MethodBulsari, K., Maple-Brown, L. J., & Falhammar, H. (2018) · HORMONES · doi:10.1007/s42000-018-0006-8 · Cited by 12
“TARTs are considered to be very common in CAH and the incidence appears to increase with age [1, 18].”
BackgroundSelf-citationPrenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 14
“The largest epidemiological study from Sweden, which included 221 men with CAH, suggested a lower rate of fatherhood compared to the general population for those born before neonatal screening implementation, while the rates were normal for those born after [15].”
Fertility and pregnancy in adrenal insufficiency
Green, D., Dineen, R., O’Reilly, M., & Sherlock, M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0088 · Cited by 13
“In a large Swedish population study of men with CAH, only those born before neonatal screening had a reduced child rate, suggesting potentially improved fertility outcomes for men with CAH in the future ( 95 ).”
BackgroundResultJiang, S., & Kuang, Y. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0893-3122 · Cited by 7
“However, the fertility issues are mainly in NC-CAH females, with the fertility in NC-CAH males reported to be normal recently [13].”
BackgroundFalhammar, H., Hirschberg, A. L., Nordenskjöld, A., Larsson, H., & Nordenström, A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad624 · Cited by 5
Self-citationNonclassic Adrenal Hyperplasia (NCAH) due to 21-hydroxylase deficiency: A cohort of 78 patients
Wan, Z., Wang, W., Zheng, S., Han, R., Xie, X., Zhao, Y., Wang, W., Sun, S., & Ye, L. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106192 · Cited by 4
Ortolano, R., Cassio, A., Alqaisi, R. S., Candela, E., Natale, V. D., Assirelli, V., Bernardini, L., Bortolamedi, E., Cantarelli, E., Corcioni, B., et al. (2023) · Children · doi:10.3390/children10091457 · Cited by 4
Fouques, C., Fatfouta, I., Hiéronimus, S., Sadoul, J., & Bongain, A. (2019) · Basic and Clinical Andrology · doi:10.1186/s12610-019-0084-8 · Cited by 4
“Spontaneous fertility of men with CAH is lower than that of the general male population [1, 2].”
BackgroundBulsari, K., & Falhammar, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65823-3 · Cited by 3
Self-citationPsychological Evaluation of Patients with Congenital Adrenal Hyperplasia (CAH)
Athanasiadis, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_10 · Cited by 3
Nationellt miljökvalitetsmål på lokal nivå
Engkvist, F. (2011)
Testicular Adrenal Rest Tumours: fisiopatologia, diagnosi e trattamento
Alcubierre, D. D., Pofi, R., & Pozza, C. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00816-5
Tonelli, F., Cotti, S., Leoni, L., Besio, R., Gioia, R., Marchese, L., Giorgetti, S., Villani, S., Gistelinck, C., Wagener, R., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.5.11
Fertility Treatment in Men with Classical and Nonclassical Congenital Adrenal Hyperplasia
Nigdelis, M. P., & Goulis, D. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_7
Bulsari, K., & Falhammar, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00076-5
Self-citationFerrari, D., & Arcolesse, L. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01686-x
Gürbüz, E., Kocaay, P., Çetin, S. K., Tepe, D., Genç, C. A., Demirtaş, Ş., Boyraz, M., Keçeli, A. M., & Gürbüz, F. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02984-3
Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia
Tschaidse, L., Auer, M. K., Nowotny, H. F., & Reisch, N. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1878713
“Epidemiological studies suggest reduced reproductive rates in affected individuals, particularly in women with classic CAH, although outcomes have improved with optimized treatment and early diagnosis (11, 18).”
Metadata
- Authors
- Falhammar, H., Frisén, L., Norrby, C., Almqvist, C., Hirschberg, A. L., Nordenskjöld, A., & Nordenström, A.
- Affiliations
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Department of Women’s and Children’s Health, Karolinska Institutet, SE-171 76 Stockholm, Sweden
- Corresponding author
- Falhammar, Henrik
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-09-13
- Volume
- 102
- Issue
- 11
- Pages
- 4191-4199
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2753947581
- Cited by
- 60
- References
- 35
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 13
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Karolinska Institutet
- Stockholms Läns Landsting (340‐2013‐5867)
- Vetenskapsrådet (340–2013-5867)
- Magnus Bergvalls Stiftelse
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- 21-hydroxylase deficiency, congenital adrenal hyperplasia, male fertility, biological children, adoption, salt-wasting phenotype, newborn screening, socioeconomic outcomes
- MeSH terms
- Child, Adopted, Adolescent, Adoption, Adrenal Hyperplasia, Congenital, Adult, Aged, Female, Fertility, Humans, Male, Middle Aged, Registries, Sweden, Cohort Studies, Case-Control Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.